Alprazolam: Research, Dosing, and Where to Buy in 2026
A research-first profile for Alprazolam (Xanax), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
Alprazolam is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, and 1 transcript dosing protocol for Alprazolam, each linked to its source.
- Also indexed as Xanax.
- 1 aggregated dosing-protocol mention from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is Alprazolam?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
Alprazolam Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
| Speaker | Source | Timestamp | Protocol | Evidence |
|---|---|---|---|---|
| Trensparent with Nyle Nayga | Togi Says Young Men Should Do Drugs. I Disagree. | 01:07:19 | Used heavily with Adderall for about 8 months after meth episode; no dose stated. | anecdotal |
Where to Buy Alprazolam in 2026
No tracked vendor recommendations for Alprazolam yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about Alprazolam. Each line links to the original source.
- "Primary outcomes included the mean difference (MD) in reduction of depression on a continuous measure of depression symptoms, and the risk ratio (RR) of the clinical response based on a dichotomous measure, with 95% confidence intervals (CI)." · van Marwijk H et al, 2012 PubMed
- "Pooled estimates of efficacy data showed a moderately large continuous mean difference (MD) at the end of trial (-5.34, 95% CI -7.48 to -3.20; I(2) = 68%)." · van Marwijk H et al, 2012 PubMed
- "The risk difference (RD) for the dichotomous measure of clinical response (50% improvement) was 0.32 in favour of alprazolam (95% CI 0.22 to 0.42; I(2) = 0%), with a number needed to treat to benefit (NNTB) of 3 (95% CI 2 to 5)." · van Marwijk H et al, 2012 PubMed
- "The RD of all-cause withdrawals did not differ between alprazolam and placebo.When depression severity was measured as a continuum the effect of alprazolam did not differ statistically or clinically from the effects of any of the conventional antidepressants combined (MD 0.25, 95% CI -0.93 to 1.43; I(2) = 55%)." · van Marwijk H et al, 2012 PubMed
- "However, for dichotomised depression severity, alprazolam had less effect than antidepressants (RR 0.86, 95% CI 0.75 to 0.99; I(2) = 37%; RD -0.11, 95% CI -0.24 to 0.01; I(2) = 58%; NNTB 9, 95% CI 4 to 100)." · van Marwijk H et al, 2012 PubMed
- "The RD of all-cause withdrawals was -0.04 (95% CI -0.07 to 0.00; I(2) = 35%), in favour of alprazolam." · van Marwijk H et al, 2012 PubMed
- "The median LOS for alprazolam overdoses was 19 h which was 1.27 (95% CI 1.04, 1.54) times longer compared with other benzodiazepines by multiple linear regression." · Isbister G et al, 2004 PubMed
- "For patients with alprazolam overdoses, 22% were admitted to ICU which was 2.06 (95% CI 1.27, 3.33) times more likely compared with other benzodiazepines after multivariate analysis adjusting for age, dose, gender, time to ingestion and co-ingested drugs." · Isbister G et al, 2004 PubMed
- "Flumazenil was administered to 14% of alprazolam patients and 16% were ventilated, which was significantly more than for other benzodiazepine overdoses (8% and 11%, respectively)." · Isbister G et al, 2004 PubMed
- "Twelve percent of alprazolam overdoses had a GCS < 9 compared with 10% for other benzodiazepines." · Isbister G et al, 2004 PubMed
Research and Studies
8 PubMed-indexed papers reference Alprazolam. Top 8 shown.
Legal Status
Alprazolam is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-04.
Frequently Asked Questions
Is Alprazolam FDA-approved?
Alprazolam is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
What dosing is reported for Alprazolam?
This page aggregates 1 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.
How much research has been published on Alprazolam?
8 PubMed-indexed paper(s) reference Alprazolam in our current research feed. See the Research and Studies section above for citations.